Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1050

1.

Hospitalisation of people with dementia: evidence from English electronic health records from 2008 to 2016.

Sommerlad A, Perera G, Mueller C, Singh-Manoux A, Lewis G, Stewart R, Livingston G.

Eur J Epidemiol. 2019 Jan 16. doi: 10.1007/s10654-019-00481-x. [Epub ahead of print]

PMID:
30649705
2.

Reoperative sternotomy is associated with increased early mortality after cardiac transplantation.

Axtell AL, Fiedler AG, Lewis G, Melnitchouk S, Tolis G, D'Alessandro DA, Villavicencio MA.

Eur J Cardiothorac Surg. 2019 Jan 10. doi: 10.1093/ejcts/ezy443. [Epub ahead of print]

PMID:
30649307
3.

Association of Primary Care Consultation Patterns With Early Signs and Symptoms of Psychosis.

Sullivan SA, Hamilton W, Tilling K, Redaniel T, Moran P, Lewis G.

JAMA Netw Open. 2018 Nov 2;1(7):e185174. doi: 10.1001/jamanetworkopen.2018.5174.

PMID:
30646393
4.

Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stress.

Föcking M, Sabherwal S, Cates HM, Scaife C, Dicker P, Hryniewiecka M, Wynne K, Rutten BPF, Lewis G, Cannon M, Nestler EJ, Heurich M, Cagney G, Zammit S, Cotter DR.

Mol Psychiatry. 2019 Jan 11. doi: 10.1038/s41380-018-0306-z. [Epub ahead of print]

PMID:
30635638
5.

Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness.

Hayes JF, Lundin A, Wicks S, Lewis G, Wong ICK, Osborn DPJ, Dalman C.

JAMA Psychiatry. 2019 Jan 9. doi: 10.1001/jamapsychiatry.2018.3907. [Epub ahead of print]

PMID:
30624557
6.

Amniotic membrane dressings: an effective therapy for SSc-related wounds.

Frech TM, McNeill C, Lebiedz-Odrobina D, Lewis G.

Rheumatology (Oxford). 2018 Dec 24. doi: 10.1093/rheumatology/key410. [Epub ahead of print] No abstract available.

PMID:
30590786
7.

Cognitive Impairment and Depression-Cause, Consequence, or Coincidence?

Halahakoon DC, Lewis G, Roiser JP.

JAMA Psychiatry. 2018 Dec 26. doi: 10.1001/jamapsychiatry.2018.3631. [Epub ahead of print] No abstract available.

PMID:
30586143
8.

Association of Maternal and Paternal Depression in the Postnatal Period With Offspring Depression at Age 18 Years.

Gutierrez-Galve L, Stein A, Hanington L, Heron J, Lewis G, O'Farrelly C, Ramchandani PG.

JAMA Psychiatry. 2018 Dec 26. doi: 10.1001/jamapsychiatry.2018.3667. [Epub ahead of print]

PMID:
30586134
9.

Depression and self-harm from adolescence to young adulthood in sexual minorities compared with heterosexuals in the UK: a population-based cohort study.

Irish M, Solmi F, Mars B, King M, Lewis G, Pearson RM, Pitman A, Rowe S, Srinivasan R, Lewis G.

Lancet Child Adolesc Health. 2018 Dec 11. pii: S2352-4642(18)30343-2. doi: 10.1016/S2352-4642(18)30343-2. [Epub ahead of print]

PMID:
30552054
10.

Prevalence of anxiety disorders and symptoms in people with hearing impairment: a systematic review.

Shoham N, Lewis G, Favarato G, Cooper C.

Soc Psychiatry Psychiatr Epidemiol. 2018 Dec 13. doi: 10.1007/s00127-018-1638-3. [Epub ahead of print] Review.

PMID:
30547211
11.

The molecular landscape of glioma in patients with Neurofibromatosis 1.

D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, DiMeco F, Ducray F, Farah W, Finocchiaro G, Goutagny S, Kamiya-Matsuoka C, Lavarino C, Loiseau H, Lorgis V, Marras CE, McCutcheon I, Nam DH, Ronchi S, Saletti V, Seizeur R, Slopis J, Suñol M, Vandenbos F, Varlet P, Vidaud D, Watts C, Tabar V, Reuss DE, Kim SK, Meyronet D, Mokhtari K, Salvador H, Bhat KP, Eoli M, Sanson M, Lasorella A, Iavarone A.

Nat Med. 2019 Jan;25(1):176-187. doi: 10.1038/s41591-018-0263-8. Epub 2018 Dec 10.

PMID:
30531922
12.

Materials used to support cognitive behavioural therapy for depression: a survey of therapists' clinical practice and views.

Tallon D, McClay CA, Kessler D, Lewis G, Peters TJ, Shafran R, Williams C, Wiles N.

Cogn Behav Ther. 2018 Dec 3:1-19. doi: 10.1080/16506073.2018.1541927. [Epub ahead of print]

PMID:
30507343
13.

Risk of schizophrenia, schizoaffective, and bipolar disorders by migrant status, region of origin, and age-at-migration: a national cohort study of 1.8 million people.

Dykxhoorn J, Hollander AC, Lewis G, Magnusson C, Dalman C, Kirkbride JB.

Psychol Med. 2018 Dec 5:1-10. doi: 10.1017/S0033291718003227. [Epub ahead of print]

PMID:
30514409
14.

Re: Accuracy of general hospital dementia diagnoses in England: Sensitivity, specificity, and predictors of diagnostic accuracy 2008-2016.

Sommerlad A, Perera G, Singh-Manoux A, Lewis G, Stewart R, Livingston G.

Alzheimers Dement. 2018 Dec 21. pii: S1552-5260(18)33583-0. doi: 10.1016/j.jalz.2018.11.001. [Epub ahead of print] No abstract available.

PMID:
30476466
15.

Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.

Kessler D, Burns A, Tallon D, Lewis G, MacNeill S, Round J, Hollingworth W, Chew-Graham C, Anderson I, Campbell J, Dickens C, Macleod U, Gilbody S, Davies S, Peters TJ, Wiles N.

Health Technol Assess. 2018 Nov;22(63):1-136. doi: 10.3310/hta22630.

16.

Information Hazards in Biotechnology.

Lewis G, Millett P, Sandberg A, Snyder-Beattie A, Gronvall G.

Risk Anal. 2018 Nov 12. doi: 10.1111/risa.13235. [Epub ahead of print]

PMID:
30419157
17.

Longitudinal association between inflammatory markers and specific symptoms of depression in a prospective birth cohort.

Chu AL, Stochl J, Lewis G, Zammit S, Jones PB, Khandaker GM.

Brain Behav Immun. 2018 Nov 7. pii: S0889-1591(18)30789-X. doi: 10.1016/j.bbi.2018.11.007. [Epub ahead of print]

18.

Dementia severity at death: a register-based cohort study.

Aworinde J, Werbeloff N, Lewis G, Livingston G, Sommerlad A.

BMC Psychiatry. 2018 Nov 1;18(1):355. doi: 10.1186/s12888-018-1930-5.

19.

Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).

Kessler DS, MacNeill SJ, Tallon D, Lewis G, Peters TJ, Hollingworth W, Round J, Burns A, Chew-Graham CA, Anderson IM, Shepherd T, Campbell J, Dickens CM, Carter M, Jenkinson C, Macleod U, Gibson H, Davies S, Wiles NJ.

BMJ. 2018 Oct 31;363:k4218. doi: 10.1136/bmj.k4218.

20.

GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?

Inkster B, Zai G, Lewis G, Miskowiak KW.

Transl Psychiatry. 2018 Oct 11;8(1):216. doi: 10.1038/s41398-018-0270-z. Review.

Supplemental Content

Loading ...
Support Center